Acrotech Biopharma has a total of 32 patents globally, out of which 26 have been granted. Of these 32 patents, more than 87% patents are active. The United States of America is where Acrotech Biopharma has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Acrotech Biopharma.
Acrotech Biopharma was founded in 2018. The Company was founded as a global platform for the commercialization of novel patented pharmaceuticals. The company introduces cutting-edge scientific products to fill gaps in the market for benefitting patients and other parties involved in the healthcare. The company intends to be a patient-focused, research-based firm that strives to make medicines available to people who require them.
Do read about some of the most popular patents of Acrotech Biopharma which have been covered by us in this article and also you can find Acrotech Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Acrotech Biopharma patent portfolio.
How many patents does Acrotech Biopharma have?
Acrotech Biopharma has a total of 32 patents globally. These patents belong to 11 unique patent families. Out of 32 patents, 28 patents are active.
How Many Patents did Acrotech Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Acrotech Biopharma Applications Filed | Acrotech Biopharma Patents Granted |
| 2023 | – | 4 |
| 2022 | 3 | 14 |
| 2021 | – | 1 |
| 2020 | – | 1 |
| 2019 | 4 | – |
| 2018 | 17 | – |
| 2017 | – | 2 |
| 2016 | 1 | – |
| 2014 | 1 | – |
| 2013 | 2 | – |
| 2011 | – | 1 |
How many Acrotech Biopharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Acrotech Biopharma File in Different Countries?
Countries in which Acrotech Biopharma Filed Patents
| Country | Patent |
| United States Of America | 10 |
| Portugal | 1 |
| Former Yugoslav Republic of Macedonia | 1 |
| Australia | 1 |
| Canada | 1 |
| Norway | 1 |
| Chile | 1 |
| Brazil | 1 |
| Slovenia | 1 |
| Germany | 1 |
| Italy | 1 |
| Denmark | 1 |
| Malta | 1 |
| Europe | 1 |
| Poland | 1 |
| Spain | 1 |
| Serbia | 1 |
| Croatia | 1 |
| Slovakia | 1 |
| Hungary | 1 |
| South Africa | 1 |
| Israel | 1 |
| India | 1 |
Where are Research Centers of Acrotech Biopharma Patents Located?
Best Acrotech Biopharma Patent
US6723338B1 is the most popular patent in the Acrotech Biopharma portfolio. It has received 85 citations so far from companies like Inex Pharmaceuticals Corporation, Transave and Neopharm.
What Percentage of Acrotech Biopharma US Patent Applications Were Granted?
Acrotech Biopharma (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Acrotech Biopharma patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Acrotech Biopharma?
| Law Firm | Total Applications | Success Rate |
| Lerner David Littenberg | 1 | 100% |
List of Acrotech Biopharma Patents
| Acrotech Biopharma Patents | Title |
| US11559486B2 | Ready-To-Use Formulation For Vincristine Sulfate Liposome Injection |
| US11541012B1 | Compositions Comprising Disodium Levofolinate |
| US11266614B2 | Oral Formulations Of Belinostat |
| US11020363B2 | Injectable Nitrogen Mustard Compositions Comprising A Cyclodextrin Derivative And Methods Of Making And Using The Same |
| US9801874B2 | Method For The Preparation Of Liposome Encapsulated Vincristine For Therapeutic Use |
| US9713616B2 | Pharmaceutical Compositions Comprising L-Leucovorin |
| EP3644970B8 | New Oral Formulations Of Belinostat |
| MK12426B | New Oral Formulation Of Belinostat |
| SKE39736T3 | New Oral Formulations Of Belinostat |
| MTP41034B | New Oral Formulations Of Belinostat |
| SI3644970T1 | New Oral Formulations Of Belinostat |
| HRP20220309T1 | New Oral Formulations Of Belinostat |
| ES2909583T3 | New Oral Formulations Of Belinostat |
| RS63046B1 | New Oral Formulations Of Belinostat |
| PL3644970T3 | New Oral Formulations Of Belinostat |
| DK3644970T3 | New Oral Formulations Of Belinostat |
| DE602018030579T2 | New Oral Formulations Of Belinostat |
| IT202200028577T2 | New Oral Formulations Of Belinostat |
| NO3644970B1 | New Oral Formulations Of Belinostat |
| HUE057999T2 | New Oral Formulations Of Belinostat |
| PT3644970T | New Oral Formulations Of Belinostat |
| CL67518B | Belinostat Solid Amorphous Dispersion; Preparation Process; Pharmaceutical Composition And Use To Treat Cancer. |
| IN438482B | New Oral Formulations Of Belinostat |
| ZA201908532B | New Oral Formulations Of Belinostat |
| CA3067723A1 | New Oral Formulations Of Belinostat |
| AU2018294561A1 | New Oral Formulations Of Belinostat |
| IL271658A | New Oral Formulations Of Belinostat |
| BR112019028088A8 | Belinostate Amorphous Solid Dispersion, Preparation Process Of Belinostate Amorphous Solid Dispersion And Pharmaceutical Composition |
| US7887836B2 | Compositions And Methods For Treating Lymphoma |
| US7247316B2 | Compositions And Methods For Treating Lymphoma |
| US7244450B2 | Compositions And Methods For Treating Lymphoma |
| US6723338B1 | Compositions And Methods For Treating Lymphoma |
What are Acrotech Biopharma key innovation segments?
What Technologies are Covered by Acrotech Biopharma?
The chart below distributes patents filed by Acrotech Biopharma